Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Radiomics × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Prostatic Neoplasms 1 Pituitary Diseases 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Lung Diseases 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Nivolumab 66 Sunitinib 63 pembrolizumab 40 cabozantinib 34 Everolimus 33 Sorafenib 32 pazopanib 31 Axitinib 31 Bevacizumab 30 Radiosurgery 29 Ipilimumab 29 Magnetic Resonance Spectroscopy 25 Interleukin-2 23 aldesleukin 21 Specimen Handling 18 Cyclophosphamide 17 lenvatinib 16 fludarabine phosphate 15 Radiotherapy 15 Interferon-alpha 15 temsirolimus 13 Peripheral Blood Stem Cell Transplantation 13 Biopsy 13 Nephrectomy 12 Gemcitabine 12 Blood Specimen Collection 10 durvalumab 9 Immunohistochemistry 9 Capecitabine 9 Mycophenolic Acid 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03552497 2020-04-06

BIII

Maastricht University

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡